DrugDashboards

Oxybutynin Chloride Extended Release

Oxybutynin Chloride · OXYBUTYNIN CHLORIDE 10 mg/1 · Tablet, Extended Release · Oral · Lannett Company, Inc.

NDC 62175-0271-37 · 100 TABLET, EXTENDED RELEASE in 1 BOTTLE · ANDA · View full market →

The short version

18 companies supply this market — deep enough that no single failure threatens the supply. The price is down 9% over the past year, to $0.0978 per unit. Put together: this looks like a healthy supply — the boring kind, which is exactly what you want.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

One drug, every price

The same NDC has different prices depending on who is paying. Units differ between rungs — compare within a rung over time, not rung against rung, unless the units match.

ⓘ How this was built
Data sources
  • CMS NADAC (pharmacy acquisition, weekly)
  • CMS Part B ASP quarterly payment limits
  • CMS Maximum Fair Prices (IRA negotiated, NDC-level)
  • Medicare Part D Spending by Drug (data.cms.gov, name-matched)
  • VA FSS / Big4 federal contract prices (va.gov, twice monthly)
  • ACA Federal Upper Limits + weighted AMP (data.medicaid.gov, monthly)
  • California SB-17 WAC filings (list price, per package)
Method

Each rung is the newest figure for this NDC from one federal price system, shown with its own unit. Part D is matched by drug name because CMS publishes no NDCs there; it is gross spending, before confidential rebates.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

  • Pharmacies pay (NADAC)$0.0978per EAinvoice-surveyed acquisition cost · Aug 19, 2026
  • Part D plans paid (avg)$12.73per dosage unitgross, before rebates — matched by drug name · 2024
  • Medicaid generic ceiling (FUL)$0.0978per TABweighted avg manufacturer price $0.0386 · Aug 1, 2026100% of what pharmacies pay — higher than 10% of drugs with this benchmark

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

$0$0.5$1.00Nov 2013Sep 2026$0.0978
155 price points · per EA · dashed = manufacturer avg (WAMP)Source: CMS NADAC

Estimated fill cost

#30 count
$2.94
#90 count
$8.81

Estimates: latest NADAC unit price × quantity. Pharmacy acquisition cost only — excludes dispensing fees, markup, and insurance terms.

Medicaid spend (2025)

$14,415
1,214 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

0● Low risk

Nothing here is signaling trouble: several manufacturers, no current shortage, no recent serious recalls, stable pricing. In drug supply, boring is the good outcome.

The score counts pressure that is already visible — fewer makers, shortages, recalls, falling prices. 0 means none of it; 100 means all of it at once. Recomputed daily · as of Sep 3, 2026

90-day shortage risk (model v2)

0.2%chance of a new FDA shortage posting for oxybutynin chloride (oral solid) in the next 90 days

OAI inspection at a producing facility (24 months) · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Regulatory

Application
ANDA078503
TE code
AB
Approval date
Feb 4, 2009
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

  • Class III · TerminatedFeb 21, 2019
    Lannett Company Inc. — Failed Dissolution Specifications

Manufacturers of Oxybutynin Chloride (Tablet, Extended Release)

LabelerStrengthFirst seenLast seen
A-S Medication SolutionsOXYBUTYNIN CHLORIDE 5 mg/1Jul 15, 2026Sep 3, 2026
Aphena Pharma Solutions - Tennessee, LLCOXYBUTYNIN CHLORIDE 5 mg/1Jul 15, 2026Sep 3, 2026
Bryant Ranch PrepackOXYBUTYNIN CHLORIDE 5 mg/1Jul 15, 2026Sep 3, 2026
PD-Rx Pharmaceuticals, Inc.OXYBUTYNIN CHLORIDE 10 mg/1Jul 15, 2026Sep 3, 2026
A-S Medication SolutionsOXYBUTYNIN CHLORIDE 10 mg/1Jul 15, 2026Sep 2, 2026
Accord Healthcare, Inc.OXYBUTYNIN CHLORIDE 5 mg/1Jul 15, 2026Sep 2, 2026
Accord Healthcare, Inc.OXYBUTYNIN CHLORIDE 10 mg/1Jul 15, 2026Sep 2, 2026
Accord Healthcare, Inc.OXYBUTYNIN CHLORIDE 15 mg/1Jul 15, 2026Sep 2, 2026
Advagen Pharma LimitedOXYBUTYNIN CHLORIDE 15 mg/1Jul 15, 2026Sep 2, 2026
Advagen Pharma LimitedOXYBUTYNIN CHLORIDE 10 mg/1Jul 15, 2026Sep 2, 2026
Advagen Pharma LimitedOXYBUTYNIN CHLORIDE 5 mg/1Jul 15, 2026Sep 2, 2026
Ajanta Pharma USA Inc.OXYBUTYNIN CHLORIDE 10 mg/1Jul 15, 2026Sep 2, 2026
Ajanta Pharma USA Inc.OXYBUTYNIN CHLORIDE 5 mg/1Jul 15, 2026Sep 2, 2026
Ajanta Pharma USA Inc.OXYBUTYNIN CHLORIDE 15 mg/1Jul 15, 2026Sep 2, 2026
American Health PackagingOXYBUTYNIN CHLORIDE 5 mg/1Jul 15, 2026Sep 2, 2026
American Health PackagingOXYBUTYNIN CHLORIDE 10 mg/1Jul 15, 2026Sep 2, 2026
Amneal Pharmaceuticals LLCOXYBUTYNIN CHLORIDE 10 mg/1Jul 15, 2026Sep 2, 2026
Amneal Pharmaceuticals LLCOXYBUTYNIN CHLORIDE 5 mg/1Jul 15, 2026Sep 2, 2026
Amneal Pharmaceuticals LLCOXYBUTYNIN CHLORIDE 15 mg/1Jul 15, 2026Sep 2, 2026
Aphena Pharma Solutions - Tennessee, LLCOXYBUTYNIN CHLORIDE 10 mg/1Jul 15, 2026Sep 2, 2026
Aphena Pharma Solutions - Tennessee, LLCOXYBUTYNIN CHLORIDE 15 mg/1Jul 15, 2026Sep 2, 2026
AvKAREOXYBUTYNIN CHLORIDE 10 mg/1Jul 15, 2026Sep 2, 2026
AvKAREOXYBUTYNIN CHLORIDE 15 mg/1Jul 15, 2026Sep 2, 2026
AvKAREOXYBUTYNIN CHLORIDE 5 mg/1Jul 15, 2026Sep 2, 2026
AvPAKOXYBUTYNIN CHLORIDE 15 mg/1Jul 15, 2026Sep 2, 2026
AvPAKOXYBUTYNIN CHLORIDE 5 mg/1Jul 15, 2026Sep 2, 2026
AvPAKOXYBUTYNIN CHLORIDE 10 mg/1Jul 15, 2026Sep 2, 2026
Chartwell RX, LLCOXYBUTYNIN CHLORIDE 10 mg/1Jul 15, 2026Sep 2, 2026
Chartwell RX, LLCOXYBUTYNIN CHLORIDE 15 mg/1Jul 15, 2026Sep 2, 2026
Chartwell RX, LLCOXYBUTYNIN CHLORIDE 5 mg/1Jul 15, 2026Sep 2, 2026
Coupler LLCOXYBUTYNIN CHLORIDE 15 mg/1Jul 15, 2026Sep 2, 2026
Coupler LLCOXYBUTYNIN CHLORIDE 5 mg/1Jul 15, 2026Sep 2, 2026
direct rxOXYBUTYNIN CHLORIDE 5 mg/1Jul 15, 2026Sep 2, 2026
Direct RxOXYBUTYNIN CHLORIDE 10 mg/1Jul 15, 2026Sep 2, 2026
Lannett Company, Inc.OXYBUTYNIN CHLORIDE 10 mg/1Jul 15, 2026Sep 2, 2026
Lannett Company, Inc.OXYBUTYNIN CHLORIDE 15 mg/1Jul 15, 2026Sep 2, 2026
Lannett Company, Inc.OXYBUTYNIN CHLORIDE 5 mg/1Jul 15, 2026Sep 2, 2026
Major PharmaceuticalsOXYBUTYNIN CHLORIDE 5 mg/1Jul 15, 2026Sep 2, 2026
Rising Pharma Holdings, Inc.OXYBUTYNIN CHLORIDE 15 mg/1Jul 15, 2026Sep 2, 2026
Rising Pharma Holdings, Inc.OXYBUTYNIN CHLORIDE 5 mg/1Jul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Oxybutynin Chloride Extended Release — NDC 62175-0271-37," retrieved September 3, 2026, https://drugdashboards.com/drug/62175027137.

Free to cite with attribution — see how the data is put together.